Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is widely used to diagnose cancer and monitor therapy. The maximum enhancement ratio (ER max ) obtained from the curve of signal intensity over time could be a biomarker to distinguish cancer from normal tissue or benign tumors. We evaluated the impact of flip angle (FA) and repetition time (TR) on the ER max values of dynamic gadobutrol-enhanced MR imaging, obtaining T 1 -weighted (T 1 W) MR imaging of VX2 tumors using 2-dimensional fast spoiled gradient echo (2D FSPGR) with various FAs (30°, 60°and 90°) at 1.5 tesla before and after injection of 0.1 mmol/kg gadobutrol. In vivo study indicated significant differences between ER max values and area under the ER-time curve (AUC 100 ) of VX2 tumors and muscle tissue, with the highest ER max and AUC 100 at FA 90°. Computer simulation also demonstrated the ER as a strictly increasing monotonic function in the closed interval [0°, 90°] for a given TR when using T 1 W FSPGR, and the highest ER value always occurred at FA 90°. The FA for the highest ER differed from that for the highest signal-to-noise or contrast-to-noise ratio. For long TR, the ER value increases gradually. However, for short TR, the ER value increases rapidly and plateaus so that the ER value changes little beyond a certain FA value. Therefore, we suggest use of a higher FA, near 90°, to obtain a higher ER max for long TR in 2D SPGR or FSPGR and a smaller FA, much less than 90°, to reach an appropriate ER max for short TR in 3D SPGR or FSPGR. This information could be helpful in setting the optimal parameters for DCE-MRI.
Introduction
Cancer incidence increases yearly, and early treatment based on early accurate diagnosis is very important. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) has been used to detect lesions and monitor treatment. Administration of a contrast agent (CA) enables differentiation of enhancement patterns of tumors from those of normal tissues. [1] [2] [3] [4] [5] Gadolinium-diethylenetriamine penta-acetic acid (Gd-DTPA; Magnevist, Schering, Berlin, Germany) is the first CA approved by the U.S. Food and Drug Administration (FDA) since 1988 as a nonspecific extracellular CA and has been widely used in DCE-MRI. 6, 7 Since then, several novel CAs have also been approved for clinical use. Gadobutrol (Gadovist, Schering, Berlin, Germany) is a neutral, hydrophilic, and macrocyclic contrast agent that has become clinically available. Its higher relaxivities compared to that of Gd-DTPA allows greater contrast between tumor and tissue. 8 -11 The enhancement ratio (ER), calculated from the MR signal intensity after injection of CA divided by that before CA injection, can be a biomarker to distinguish cancers from normal tissue. The relative maximum ER (ER max ) can also differentiate malignant from benign masses in some tumors. 12, 13 ER max varies with pulse sequence in addition to magnetic field, category of CA, injection dosage of CA, and time interval after injection of CA. 10, 14 A T 1 -weighted (T 1 W) spoiled gradient echo (SPGR) pulse sequence is most commonly used in DCE-MRI, and its signal intensity depends on such scanning parameters as flip angle (FA), repetition time (TR), proton density, and echo time (TE). We investigated the impact of FA and TR on the ER of dynamic gadobutrol-enhanced MR imaging.
VX2 tumors are hypervascular adenocarcinomas often used as a model for human disease and can be implanted in many organs for preclinical studies. In this study, we implanted VX2 tumor cells into one thigh of each of 18 New Zealand rabbits for imaging the thigh and there were no obvious motion artifacts during DCE-MRI. [15] [16] [17] We used the rabbit VX2 tumor to compare ER max values obtained using T 1 W FSPGR with various FAs. In addition, we examined the effects of FA and TR on the ER values by computer simulation and explored the theoretical approach of optimal FA for the highest ER.
Materials and Methods

MR imaging of animals
Our institutional animal care and use committee approved the protocol for animal use.
We divided 18 rabbits into 3 groups of 6 animals each that were subjected to MR imaging using flip angles of 30°, 60°, or 90°. Each rabbit was implanted with VX2 tumor cells in a concentration of about 1 © 10 6 /mL that was injected intramuscularly into its left thigh using a 0.5 mL VX2 tumor cell suspension via a 19-gauge needle. The injected site was shaved and disinfected with ethanol and povidone iodine. The cell suspension was prepared from a mass removed from a rabbit carrying a VX2 tumor and placed in a cell culture dish with normal saline. The tumor mass was washed 3 times, chopped into very small pieces, and digested with trypsin to form cell suspension.
Two weeks after tumor implantation, the rabbits underwent MR examinations after being anesthetized with 16 mg/kg Zoletil 50 (VIRBAC Animal Health, Carros, France) and 14 mg/kg Rompun 2% (Bayer Korea Ltd., Kyonggi-do, Korea) and inserted a 23-gauge butterfly needle into an ear vein for gadobutrol injection. All MR imaging studies were performed on a 1.5-tesla whole-body MR scanner (Signa HDxt, GE Medical Systems, Milwaukee, WI, USA) with an 8-channel knee coil. The rabbit's left thigh was placed into a knee coil with the VX2 mass in the center. A phantom of 2% agarose and a phantom of water were put aside the thigh for references. A 3-plane localizer scan was followed by a conventional spin echo (CSE) pulse sequence for T 1 Following acquisition of 4 precontrast images, each rabbit was administered 0.1 mmol/kg gadobutrol by bolus injection through the ear vein that was flushed with one mL of saline. Scans were subsequently performed continuously for 3 min, after which consecutive scans were performed with one scan per minute. The total scan time for DCE-MRI was 30 min. All acquired MR images were transferred to an Advantage Window workstation for analysis.
For data analysis, several regions of interest (ROIs) were chosen from the rims of tumors, muscle, phantom, and background. Angiogenesis at the periphery of tumors resulted in stronger enhancement of the rims than cores of the tumors, and accumulation of more gadobutrol in the rims of tumors enhanced the MR signal. The ROIs from the rims of tumors were selected according to the regions most enhanced in the second DCE images after injection of gadobutrol.
The T 1 and T 2 values of tumor and muscle were obtained by least squares fitting to the values of ROIs of tumor and muscle according to Eqs. [1] and [2] respectively using commercial software (Sigmaplot, version 9.01, Systat Software, San Jose, CA, USA.
where S is the MR signal intensity and M is a constant. Because the spin echo signal can be expressed as 18 :
where M 0 is magnetization combined with the electric gain, and M 0 can be determined by dividing M by e ÀTE=T 2 according to Eqs. [1] and [3] once T 1 and T 2 are obtained. Afterwards, we obtained the average T 1 , T 2 , and M 0 of tumor and muscle of the 18 rabbits and used the data for computer simulation.
The ER value was calculated according to Eq. [4] :
where S pre and S post are the MR signal intensity normalized with the 2% agarose phantom and obtained before (S pre ) and after (S post ) gadobutrol injection. We averaged the signal intensities from 4 MR images obtained before gadobutrol injection to determine the MR signal intensity before gadobutrol injection.
We could obtain the ER-time curve for each ROI and determine the ER max for each ER-time curve. The area under the curve of each ER-time curve (AUC 100 ) was calculated according to Eq. [5] :
where ft n g was the time series of dynamic scans, t n was the nth term and ER n was the ER obtained at t n after gadobutrol injection. ER 0 was obtained before gadobutrol injection at t 0 = 0 s and was equal to one. AUC 100 was obtained by summing every trapezoid area under the ER-time curve from 0 to 100 s ( j = 6). We used nonparametric Wilcoxon test for the statistical analysis of T 1 , T 2 , ER max , and AUC 100 between the tumor and muscle; P < 0.05 was considered to represent significant difference. We used nonparametric Kruskal-Wallis test to compare ER values obtained from each of the 3 groups (scanned with FA of 30°, 60°, or 90°). There was a significant difference in the ER max or AUC 100 among these 3 groups if P < 0.05.
After acquisition of the ER, we calculated the concentration, C, of gadobutrol according to Eq. [6] :
where B ¼ ð1 À e ÀTR=T 10 Þ ð1 À cosðFAÞe ÀTR=T 10 Þ and the r 1 value is 4.7 mM ¹1 s ¹1 . 19 Then, we determined the average maximum concentrations of tumor (C max_t ) and muscle (C max_m ) of the 18 rabbits. The average noise (·) of the DCE-MRI was obtained by averaging the standard deviation of background signal measured from the 18 rabbits. C max_t , C max_m , and · were used for computer simulation.
After experiments were completed, rabbits were sacrificed under deep anesthesia with CO 2 . The left thigh with implanted VX2 tumor was then removed and fixed in 10% formalin. Paraffin-embedded sections were stained with hematoxylin and eosin for visualization of VX2 tumors under a microscope.
Computer simulation
The signal-to-noise ratio (SNR), ER, and contrast-to-noise ratio (CNR) values for SPGR were calculated according to Eqs. [7] through [10] 20,21 :
where SNR t is the SNR of tumor, and SNR m , that of muscle.
Here, the M 0 , T 10 , T 20 of tumor and muscle and were determined from the MR imaging study mentioned above. Ignoring the impact of field inhomogeneity, we assumed T 2 * = T 2 . 22 The T 1 and T 2 values of tumor and muscle after gadobutrol injection were calculated according to Eqs. [11] and [12] 23 :
where C is the concentration of the contrast agent, r 1 is longitudinal relaxivity, r 2 is transverse relax-ivity, T 1 is the longitudinal relaxation time and T 2 , the transverse relaxation time after CA injection, and T 10 is the longitudinal relaxation time and T 20 , the transverse relaxation time in the absence of CA. Concentrations C max_t and C max_m were also obtained from the in vivo MR imaging studies mentioned above. In the calculation, we used the value 4.7 mM ¹1 s ¹1 for r 1 and 6.8 mM ¹1 s ¹1 for r 2 . 19 We evaluated the SNR, ER, and CNR values of tumor and muscle for various FAs (one to 90°) and TRs (5 to 100 ms) with concentrations of C max_t and C max_m and those of tumor with 0.5 mM gadobutrol concentration. Figure 1 shows CSE images for T 1 measurements and Fig. 2 , those for T 2 measurements of tumor and muscle. MR signal intensity increased with TR for a given TE and decreased with TE for a given TR. There were 2 phantoms; one was water and the other was 2% agarose. The water phantom was used to double-check whether the water content in the agarose phantom evaporated. The different inherent proton density and relaxation times of these 2 phantoms yielded different MR signal intensities. In particular, the SNR of water was higher than that of 2% agarose (Fig. 2) , which was expected because of the higher proton density and T 2 relaxation time of water. The T 10 values of tumor were 1812 « 257 ms and of muscle, 1517 « 133 ms. The T 20 values of tumor were 59.17 « 8.43 ms and of muscle, 31.37 « 3.43 ms. There were significant differences of T 10 and T 20 values between tumor and muscle (P < 0.01). The average value of M 0 for tumor was 7456 and for muscle, 5352. Figure 3 shows several representative dynamic gadobutrol-enhanced MR images from one rabbit. The contrast between tumor and muscle was low before gadobutrol injection. Right after the bolus injection of gadobutrol, the MR signal intensity of the tumor increased more than that of muscle, and consequently, the contrast between tumor and muscle increased. The contrast increased with time, reached a maximum value, and gradually decreased with time as a result of the excretion of gadobutrol. Figure 4a shows the ER-time curves of tumor and muscle obtained with FA/TR/TE = 90°/100 ms/ 1.3 ms using an FSPGR pulse sequence. The ER of the tumor was higher than that of muscle. Figure 4b shows the ER values of tumor obtained from the same TR/TE (100 ms/1.3 ms), but with various FA (30°, 60°, and 90°). The ER max obtained with a 90°F A was larger than that obtained with FAs of 60°or 30°. Table lists the ER max and AUC 100 values obtained with various FAs. ER max and AUC 100 values in the tumor differed significantly from these values in the muscle among the 3 groups scanned with various FAs (P < 0.05). The noise value, , was 17.57; the C max_t was 0.13 « 0.04 mM; and the C max_m was 0.03 « 0.01 mM. The VX2 tumor was verified by hematoxylin and eosin staining (Fig. 5) . Figure 6 shows SNR values of tumor and muscle as a function of TR and FA. The SNR of tumor was higher than that of muscle for any TR and FA, and the concentration of gadobutrol was 0.13 mM in tumor and 0.03 mM in muscle. The SNR increased with TR for a given FA for both tumor and muscle. However, SNR values increased with FA first and then decreased for some given TR. There was an optimal FA for the maximum SNR (SNR max ), and the optimal FA increased with TR as well. Tumor also had higher ER than muscle for each corresponding TR and FA (Fig. 7) . The ER values decreased with TR but increased with FA for both tumor and muscle. Figure 9a shows the CNR values as a function of TR and FA. CNR first increased with FA and then decreased for a given TR. The optimal FA was basically defined as that corresponding to the maximum value of SNR, CNR, and ER for each TR (Figs. 7-9 ). There was an op- timal FA for the maximum CNR (CNR max ), and the optimal FA increased with TR as well. The optimal FA for CNR max differed from that for SNR max . SNR max , ER max and CNR max for given TR and FA values were higher for a tumor with a higher concentration of gadobutrol (0.5 mM) than a tumor with a concentration of 0.13 mM gadobutrol (Figs.  8 and 9b ).
Results
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Discussion
In this study, we investigated the impact of FA and TR on the ER max of FSPGR T 1 -weighted gadobutrol-enhanced MR imaging using an in vivo VX2 tumor model and computer simulation. In general, FA and TR are the 2 dominant factors that influence the MR signal intensity of SPGR T 1 W images. There were significant differences in ER max and AUC 100 of ER-time curves between the tumor and muscle. The ER max value increased with FA (0°-90°) for a given TR for both computer simulation and single dosage gadobutrol-enhanced MR imaging. Furthermore, computer simulations demonstrated increased ER max values with a higher concentration of gadobutrol (0.5 mM).
Computer simulation demonstrated that the ER value also increased with FA for a given TR in the closed interval [0, 90°] in tumors with a higher concentration of gadobutrol (0.5 mM). After injecting 0.1 mmol/kg gadobutrol, we obtained a C max of gadobutrol of 0.13 mM in tumor. A higher injected dosage is expected to yield a higher concentration of gadobutrol in tumor. We assumed a gadobutol concentration of 0.5 mM in tumor with an injected dosage higher than 0.1 mmol/kg. From the result of simulation, we demonstrated the same tendency for monotonic increase of ER max in the interval [0, 90°] for concentrations of both 0.13 and 0.5 mM. Therefore, it is expected that the tendency of optimal FA is similar for tumor concentration between 0.13 to 0.5 mM. The common routine dosages used clinically are 0.1 mmol/kg or sometimes 0.2 mmol/kg. A tumor concentration of 0.5 mM far exceeds clinically used double-dosage injection. Therefore, an estimated dosage of 0.5 mM is sufficient.
The scanning time of the T 1 W SPGR pulse sequence is shorter, and the sequence has been widely used in DCE-MRI. The acquired MR signal intensity, shown in Eq. [7] , depends on TR, TE, FA, T 1 , T 2 , and proton density. T 1 , T 2 , and proton density are the intrinsic properties of tissues and are independent of MR imaging pulse sequences. TE usually is set to the minimum value in the T 1 W The ER value increases gradually with FA for longer TR and increases rapidly and plateaus for short TR. Consequently, ER values change little beyond some FA for a short TR. The 3-dimentional (3D) SPGR sequence is commonly used to cover a large volume of interest. A short TR and small FA are often used in 3D SPGR to shorten scan time. However, 2-dimensional (2D) SPGR is more suitable than 3D SPGR for fewer slices of interest. A shorter TR yields a low SNR with small coverage. Therefore, a longer TR is often used in 2D SPGR than that in 3D SPGR, which produces a more significant effect of FA on ER. In general, the choice of a larger FA will help increase ER in 2D SPGR, even in 3D SPGR. 26, 27 Angiogenesis generally produces greater blood flow in tumor than normal tissue. Use of a larger FA increases the effect of inflow, and the inflow effect could help to differentiate tumor from normal tissue. However, use of a larger FA increases the specific absorption rate (SAR), so the decision to use a larger FA to achieve a higher ER requires consideration of whether the SAR is within the permitted limitation. Nevertheless, the SAR of SPGR with FA 90°is less than that of fast spin echo (FSE) with FA 90°and 180°. Therefore, the SAR of SPGR with FA 90°is acceptable.
Compared to Gd-DTPA, gadobutrol has the benefit of less injection volume because of its high concentration formula. Images are sharper with gadobutrol than images obtained with Gd-DTPA in angiography. 21, 28 Gadobutrol can be applied in tumor diagnosis as well. Its higher relaxivity than that of Gd-DTPA can produce higher ERs than those with Gd-DTPA. 29, 30 In addition, gadobutrol has a good safety profile. 31 In the future, CAs with higher relaxivity will be helpful for increasing ER.
The computer simulation method of this study can be applied in humans with any kind of Gdbased contrast agent once the T 10 and r 1 values of human organs are known. In this study, we used a conventional spin echo pulse sequence to measure T 10 values because CSE can produce high quality images and take less scan time than conventional inversion recovery (CIR) pulse sequences. Though other fast imaging pulse sequences, such as LookLocker or SPGR with various flip angles, can be used to obtain T 10 in shorter scan time, 32,33 their image quality is worse than that with conventional spin echo. Many factors, including temperature, main field strength, and tissue type, may influence r 1 values, and acquisition of the actual r 1 in vivo is difficult. In this study, r 1 in the tissue is assumed to equal that in plasma in vitro at 37°C for 1.5T. 21 However, acquisition of an accurate r 1 in vivo remains a challenge. Nevertheless, even with such an approximation, the effect of FA and TR on ER can be estimated. The different assumption of r 1 values may change the values of SNR, CNR, AUC 100 , and ER max but will not change the behavior of the ER max value versus the FA, i.e., the increased ER max with FA for a given TR in the closed interval [0, 90°].
Conclusions DCE-MRI is popular for diagnosing lesions and monitoring therapy. The ER max and AUC 100 obtained from ER-time curves could differentiate tumor from normal tissue. The maximum ER max occurs at FA 90°according to in vivo study, computer simulation, and theoretical calculation. For short TR, the ER value was shown to increase rapidly with FA and then plateau. In conclusion, a higher FA, close to 90°, can obtain a higher ER max for long TR in 2D SPGR or FSPGR, and a smaller FA, much less than 90°, can still reach appropriate ER values for short TR in 3D SPGR or FSPGR.
where FA is the flip angle, TR is the repetition time, TE is the echo time, T 1 is the longitudinal relaxation time, T [A2] and rearranging it yields ½1 À B Á ER cosðFAÞe
The natural logarithm of
multiplied by À1 TR on each side yields
where C is the concentration of the contrast agent and r 1 is the longitudinal relaxivity. Therefore, the concentration can be expressed as
